Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METARAMINOL Cause Respiratory failure? 37 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Respiratory failure have been filed in association with METARAMINOL. This represents 22.4% of all adverse event reports for METARAMINOL.

37
Reports of Respiratory failure with METARAMINOL
22.4%
of all METARAMINOL reports
21
Deaths
4
Hospitalizations

How Dangerous Is Respiratory failure From METARAMINOL?

Of the 37 reports, 21 (56.8%) resulted in death, 4 (10.8%) required hospitalization, and 2 (5.4%) were considered life-threatening.

Is Respiratory failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METARAMINOL. However, 37 reports have been filed with the FAERS database.

What Other Side Effects Does METARAMINOL Cause?

Condition aggravated (40) Drug ineffective (23) Hypotension (19) Anaphylactic reaction (15) Maternal exposure during pregnancy (12) Confusion postoperative (11) Foetal exposure during pregnancy (11) Mental status changes postoperative (11) Metabolic alkalosis (11) Rash (11)

What Other Drugs Cause Respiratory failure?

PREDNISONE (2,299) CYCLOPHOSPHAMIDE (2,096) RITUXIMAB (1,838) TACROLIMUS (1,758) METHOTREXATE (1,685) DEXAMETHASONE (1,603) MYCOPHENOLATE MOFETIL (1,469) METHYLPREDNISOLONE (1,442) PREDNISOLONE (1,346) VINCRISTINE (1,120)

Which METARAMINOL Alternatives Have Lower Respiratory failure Risk?

METARAMINOL vs METAXALONE METARAMINOL vs METFORMIN METARAMINOL vs METFORMIN\PIOGLITAZONE METARAMINOL vs METFORMIN\ROSIGLITAZONE METARAMINOL vs METFORMIN\SAXAGLIPTIN

Related Pages

METARAMINOL Full Profile All Respiratory failure Reports All Drugs Causing Respiratory failure METARAMINOL Demographics